Home › Research › How common it is
The Association between Glaucoma and Dementia in a National Cohort of All of Us Participants
Kenneth Pham, Rebecca Salowe, Isabel Di Rosa, Ali G. Hamedani, Gui‐Shuang Ying, Joan M. O’Brien. Ophthalmology, 2025-09-16
Topic: Risk, prevention and care in population studies
Plain-language summary
Among the 393 497 All of Us participants with linked EHRs, we identified 9444 individuals (2.40%) with glaucoma diagnoses (excluding participants with diagnoses of dementia before glaucoma) and 37 776 matched controls without glaucoma. During the observation period (median, 6.5 years; interquartile range, 3.3-10.7 years), dementia was diagnosed in 1127 individuals (2.39%). Glaucoma was associated with a significantly increased risk of all-cause dementia (adjusted hazard ratio [aHR], 1.23; 95% confidence interval [CI], 1.08-1.40), Alzheimer's disease (aHR, 1.60; 95% CI, 1.26-2.02), and vascular dementia (aHR, 1.38; 95% CI, 1.04-1.83). Among glaucoma subtypes, primary open-angle glaucoma (POAG, N = 5756) and normal-tension glaucoma (NTG, N = 1106) were linked to an elevated risk of Alzheimer's disease (POAG: aHR, 1.48, 95% CI, 1.11-1.96; NTG: aHR, 1.87, 95% CI, 1.09-3.18), whereas angle-closure glaucoma (N = 3150) showed no significant association (aHR, 1.49; 95% CI, 0.91-2.27). Glaucoma was associated with an increased risk of all-cause dementia across the three APOE genotypes assessed, (ε2ε3 > ε3ε3 > ε3ε4). Glaucoma was associated with a higher risk of dementia across APOE genotypes, with varying associations among glaucoma and dementia subtypes. FINANCIAL DISCLOSURE(S): The author(s) have no proprietary or commercial interest in any materials discussed in this article.
What this study adds
Evidence grade: Moderate
This is a follow-up (cohort) study of 5,756 participants. In this large cohort, people with glaucoma were more likely to later be diagnosed with all-cause dementia, Alzheimer's disease, and vascular dementia, but this kind of study cannot show that glaucoma causes dementia. Reported effect size: 2.40%; 2.39%.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Pham, K., Salowe, R., Di Rosa, I., Hamedani, A. G., Ying, G., & O’Brien, J. M. (2025). The Association between Glaucoma and Dementia in a National Cohort of All of Us Participants. Ophthalmology. https://doi.org/10.1016/j.ophtha.2025.09.007
Vancouver
Pham K, Salowe R, Di Rosa I, Hamedani AG, Ying G, O’Brien JM. The Association between Glaucoma and Dementia in a National Cohort of All of Us Participants. Ophthalmology. 2025. doi:10.1016/j.ophtha.2025.09.007. PMID: 40961986.
BibTeX
@article{pham2025-40961986,
author = {Pham, Kenneth and Salowe, Rebecca and Di Rosa, Isabel and Hamedani, Ali G. and Ying, Gui‐Shuang and O’Brien, Joan M.},
title = {{The Association between Glaucoma and Dementia in a National Cohort of All of Us Participants}},
journal = {Ophthalmology},
year = {2025},
doi = {10.1016/j.ophtha.2025.09.007},
pmid = {40961986},
url = {https://doi.org/10.1016/j.ophtha.2025.09.007}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.
Key findings
- Among the 393 497 All of Us participants with linked EHRs, we identified 9444 individuals (2.40%) with glaucoma diagnoses (excluding participants with diagnoses of dementia before glaucoma) and 37 776 matched controls without glaucoma.
- During the observation period (median, 6.5 years; interquartile range, 3.3-10.7 years), dementia was diagnosed in 1127 individuals (2.39%).
- Glaucoma was associated with a significantly increased risk of all-cause dementia (adjusted hazard ratio [aHR], 1.23; 95% confidence interval [CI], 1.08-1.40), Alzheimer's disease (aHR, 1.60; 95% CI, 1.26-2.02), and vascular dementia (aHR, 1.38; 95% CI, 1.04-1.83).
- Among glaucoma subtypes, primary open-angle glaucoma (POAG, N = 5756) and normal-tension glaucoma (NTG, N = 1106) were linked to an elevated risk of Alzheimer's disease (POAG: aHR, 1.48, 95% CI, 1.11-1.96; NTG: aHR, 1.87, 95% CI, 1.09-3.18), whereas angle-closure glaucoma (N = 3150) showed no significant association (aHR, 1.49; 95% CI, 0.91-2.27).
- Glaucoma was associated with an increased risk of all-cause dementia across the three APOE genotypes assessed, (ε2ε3 > ε3ε3 > ε3ε4).
Why it matters
In this large cohort, people with glaucoma were more likely to later be diagnosed with all-cause dementia, Alzheimer's disease, and vascular dementia, but this kind of study cannot show that glaucoma causes dementia. It does not test any treatment or prevention, so it does not show that treating glaucoma would lower dementia risk.
New to this subject? Start with our plain-English guide: Alzheimer's in numbers →
Study details
- Study designcohort study
- Participants5,756
- Effect size2.40%; 2.39%
- Evidence strengthModerate
How this study scored 56/100
Published in a peer-reviewed journal, and it is a cohort study following people over time. Scored zero for randomized / blinded because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (Ophthalmology) |
| Journal's citation record | 3 / 4 | Ophthalmology: journal h-index 371 (OpenAlex, 2026-10-29) |
| Study design | 7 / 12 | A cohort study following people over time |
| Strength of evidence | 3 / 5 | Rated “moderate” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 4 / 5 | 2025 — within 3 year(s) of the newest study here |
| Sample size | 3 / 4 | 5,756 participants |
| Effect reported | 2 / 3 | Effect reported as a number, without an interval or test |
| Studied in people | 3 / 3 | Studied in people (participant count stated) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 1 / 7 | Cited 3 times (OpenAlex, 2026-10-10) |
| Citations per year | 1 / 5 | 1.0 citations a year over 3 year(s) since 2025 |
| Impact for its field and year | 2 / 6 | Cited 2.3× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 0 / 6 | No other study in this library cites it |
| Still being cited | 1 / 4 | Cited 3 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 2 / 4 | Last-listed author Joan M. O’Brien: h-index 39 (OpenAlex, whole career) |
| Institution's track record | 2 / 3 | University of Pennsylvania: institution h-index 1,859 (OpenAlex) |
| Multicenter collaboration | 1 / 3 | OpenAlex lists 3 institution(s) in 1 country |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 40961986) |
| Free to read | 2 / 2 | Free to read |
| Total | 56 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
- DOI: 10.1016/j.ophtha.2025.09.007
- PubMed: 40961986
- Original source →
- Free full text: Ophthalmology →
Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).
Related
Studies in the library that share something with this one. The line above each title says what.
Studies this one cites
Referenced by this study and also in the alzhub library, so you can read them here.
Related studies in How common it is from nearby years
Also tagged “biobank”
1,084 studies in the library carry the topic tag “biobank”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 1,084 tagged studies.